[1] Garber K.Energy deregulation:licensing tumors to grow.Science,2006,312（5777）:1158.
[2] Hsu PP,Sabatini DM. Cancer cell metabolism: Warburg and beyond.Cell,2008,134（6）:703.
[3] Bouwman FG,Claessens M,Marleen A,et al. The physiologic effects of caloric restriction are reflected in the in vivo adipocyte-enriched proteome of overweight/obese subjects.
J Proteome Res,2009,8（12）:5532-5540.
[4] Zhang N,Fu ZX,Linke S,et al. The asparaginyl hydroxylase factor inhibiting HIF-1α is an essential regulator of metabolism. Cell Metab,2010,11（5）:364-378.
[5] Teslovich TM,Musunuru K,Smith AV,et al. Biological, clinical,and population relevance of 95 loci for blood lipids. Nature,2010,466（7307）:707-713.
[6] 秦波,郭学强,徐存拴. 大鼠再生肝8 种细胞的PPAR γ 信号通路相关基因转录谱预示脂类代谢活动.河南科学,2010,28（7）：786-790.
[7] Bard-Chapeau EA,Li S,Ding J,et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell, 2011,19（5）:629-639.
[8] Zhao P,Zhang W,Wang SJ,et al. HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in HCC cells. Hepatology,2011,54（6）: 2012-2024.
[9] Ma X,Xu L,Wang S,et al. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis. J Hepatol,2011,55（2）: 445-452.
[10] Whittle AJ,Carobbio S,Martins L,et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell,2012,149（4）:871-885.
[11] Nikolaou K,Tsagaratou A,Eftychi C,et al. Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis,inflammation, fibrosis,and cancer. Cancer Cell,2012,21（6）:738-750.
[12] Min HK,Kapoor A,Fuchs M,et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab,2012,15（5）:665-674.
[13] Tomita K,Suzuki T,Oshikawa T,et al. p53/p66Shc-mediated signaling contributes to the progression of nonalcoholic steatohepatitis in humans and mice. Hepatology,2012,57（4）:837-843.
[14] Ichimura A,Hirasawa A,Poulain-Godefroy O,et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature,2012,483（7389）:350-354.
[15] Bradfield JP,Taal HR,Timpson NJ,et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet,2012,44:526-531.
[16] Zhou LK,Xu L,Ye J,et al. Cidea promotes hepatic steatosis by sensing dietary fatty acids. Hepatology,2012,56（1）:95-107.
[17] Ke AW,Shi GM,Zhou J,et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology,2009,49（2）:491-503.
[18] Shi GM,Ke AW,Zhou J,et al. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology,2010,52（1）:183-196.
[19] Ke AW,Shi GM,Zhou J,et al. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology,2011,140（5）:1629-41.e15.
[20] Das SK,Eder S,Schauer S,et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science,2011,333（6039）:233-238.
[21] Ronald JA,Simone Denis W,Ruiter J,et al. 2,6-dimethylheptanoyl-CoA is a specic substrate for long-chain acyl-CoA dehydrogenase（LCAD）:evidence for a major role of LCAD in branched-chain fatty acid oxidation. Biochimica Biophysica Acta,1998,1393:35-40.
[22] Weiping Le,Azfar S,Abbas,et al. Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial β-oxidation of unsaturated fatty acids. Biochimica Biophysica Acta,2000,1485: 121-128.
[23] Clark-Taylor T,Benjamin E,Clark-Taylor. Is autism a disorder of fatty acid metabolism Possible dysfunction of mitochondrial b-oxidation by long chain acyl-CoA dehydrogenase. Med Hypot,2004, 62:970-975.
[24] Zhang DY,Liu ZX,Choi CS,et al. Mitochondrial dysfunction due to long-chain acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. PNAS,2007,104（43）:17075-17080.
[25] Irie J,Reck B,Wu YH,et al. Genome-wide microarray expression analysis of CD4 + T cells from nonobese diabetic congenic mice identifies Cd55（Daf1） and acadl as candidate genes for type 1 diabetes. J Immunol,2008,180:1071-1079.
[26] Cox KB,Liu J,Tian LQ,et al. Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency. Lab Invest,2009,89:1348-1354.
[27] Hirschey MD,Shimazu T,Goetzman E,et al. SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation. Nature, 2010,464（7285）:121-125.
[28] Xie BX,Zhang H,Yu L,et a1. The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP. Asian J Androl,2010,12（3）:405-414.
[29] Xie BX,Zhang H,Wang J,et a1. Analysis of differentially expressed genes in LNCaP prostate cancer progression model. J Androl,2011,32:170-182.
[30] Mason P,Liang B,Carter K,et a1. SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One,2012,7（3）:e33823.
[31] Bonnet S,Archer SL,Allalunis-Turner J,et al. A mitochondria-K + channel axis is suppressed in cancer and its normalization promotes apoptosis andbinhibits cancer growth. Cancer Cell,2007,11:37-51.
[32] Randle PJ,Garland PB,Hales CN,et al. The glucose fatty acid cycle:its role in insulin sensitivity and metabolic disturbance of diabetes mellitus. Lancet,1963,1:785-789.
[33] Wahr JA,Childs KF,Bolling SF. Dichloroacetate enhances myocardial functional and metabolic recovery following global ischemia. J Cardiaothor Vascular Anesth,1994,8:192-197.
[34] Schwartz GG,Greyson C,Wisneski JA, et al. Inhibition of fatty acid metabolism alters myocardial high-energy phosphates in vivo. Am J Physiol,1994,267:224-231.
[35] Clarke B,Wyatt KM,McCormack JG. Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts:Evidence for an indirect mechanism. J Mol Cell Cardiol,1996,28:341-350.
[36] Wenzel U,Nickel A,Daniel H. Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis. J Nutr,2005,135（6）:1510-1514. |
